Baby Oil
Mineral oil and plant oil baby oils marketed for ages 0-5. No within-row split per Step 0 lock — the categorical 8-panel metal difference between mineral and plant variants is not documented in the literature batch reviewed for the lock.
This page is a Step 0 lock scaffold for Cat 2 Row 2. Literature evidence will be populated as routed source pages accumulate per the synthesis workflow in CLAUDE.md Part 9. The Step 0 lock document at Category2_Clean_vs_Contaminated_Splits.md is the canonical reference for the row’s clean-vs-contaminated framing and platform attribution.
Literature scope
The Heavy Metal Index source corpus is currently focused on food and food-contact materials. This page documents an HMTc Taxonomy v2.0 row in the category this product class for which no peer-reviewed primary or government sources have yet been ingested. The page exists as the routing destination for future ingest. Until sources land, the literature-evidence sections below are deliberately empty rather than guessed; HMTc certification thresholds for products in this row continue to be developed under the certification program at heavymetaltested.com, not on this public page.
Who this page is for
Brand legal teams evaluating HMTc Cat 2 certification for the Baby Oil row need to know what the cited literature reports per panel metal, what the applicable regulatory caps are, and how this row relates to its clean-contaminated pair (when applicable). Retailer compliance teams stocking the children’s personal care aisle need the row-level assortment-eligibility view. HMT&C certification thresholds for products in this row are developed under the certification program at heavymetaltested.com, not on this page.
Methodology
This page reports what the cited sources say about heavy-metal concentrations in the Baby Oil row. Speciation is non-substitutable per CLAUDE.md Part 14 (iAs vs tAs, MeHg vs tHg, Cr-VI vs total Cr). Basis is preserved (finished-product as sold). Non-detect handling follows each source’s convention. Pooling avoided across LOD/LOQ, period, geography, and analytical-basis differences. HMT&C certification thresholds for products in this row are developed under the certification program at heavymetaltested.com, not on this page; this public page reports literature evidence only.
Cat 2 dose-pathway methodology supplement (per OPERATING.md Part 7 initiative 3.1) is documented at cat-2-non-ingestion-exposure-pathways. That supplement governs how dermal, inhalation, accidental-ingestion, and trans-placental exposure factors apply to this row.
Literature Evidence Summary
Pending: regenerated by tools/evidence/apply-product-hmtc-evidence-summaries.mjs once sources route to this row and the pooling engine emits aggregate rows. Row 2 of the Cat 2 Step 0 lock is currently in scaffold state pending corpus ingest of Cat 2 papers from the Children Personal Care Papers pile in raw/Manual Fetch Kimi /.
Source Evidence Inventory
Hand-curated section. Populated by the synthesis pass as Cat 2 sources are ingested and route to this row. Initial scaffold state: zero contributing sources.
Broad Product Context: Author-Scope Index
Pending: regenerated by tools/evidence/apply-product-broad-context.mjs once broad-scope Cat 2 sources route to this page.
Federal/Regulatory Limits vs Field Findings
Pending. Cat 2 regulatory landscape is fragmented: cosmetics under FDA FD&C Act adulteration provisions (no binding finished-product heavy-metal limits); sunscreens under FDA OTC drug monograph; toothpaste under FDA cosmetic + OTC drug regulation; state-level cosmetic heavy-metal laws (Washington TFCA 2025, New York TCCP). EU 1223/2009 Annex II/III addresses cosmetic ingredient restrictions but not finished-product action levels. Awaiting agency-page ingest.
Levers to reduce contamination
The Cat 2 Step 0 lock framework distinguishes clean-formulation rows from contaminated-platform rows. For this row, the levers below are ordered by impact magnitude based on the literature evidence base and per the Step 0 lock attribution of platform-level metal load. Brand-legal teams evaluating HMTc Cat 2 certification eligibility for this row should treat the formulation/sourcing levers as the dominant compliance pathway.
- Sourcing levers on platform ingredients. Even without a clean alternative within the row, supplier-grade differences within the platform are material.
- Refining levers.
- Testing/QC levers: lot-level ICP-MS on raw materials and finished product.
- Regulatory levers.
How standards math uses this page
The percentile arithmetic that informs HMTc Cat 2 thresholds for this row lives on the staff Standards Workbench (data/workbench/standards/baby-oil.md, to be generated). This public page reports literature evidence; the workbench applies the Cat 2 methodology (which includes the OPERATING.md Part 7 initiative 3.1 non-ingestion-exposure supplement at cat-2-non-ingestion-exposure-pathways) to produce candidate threshold values. The gap between literature evidence and HMTc thresholds is named honestly on the workbench, not hidden.
Historical recalls and enforcement
Cat 2 (children’s personal care) regulatory enforcement is fragmented: cosmetics fall under FDA FD&C Act adulteration provisions without binding finished-product heavy-metal action levels; sunscreens fall under FDA OTC drug monograph; toothpaste falls under FDA cosmetic + OTC drug regulation. State-level enforcement is more active: Washington State Toxic-Free Cosmetics Act 2025 sets heavy-metal limits for cosmetic products sold in Washington; New York Toxic Children’s Cosmetic Products Act sets limits for children’s makeup. California Prop 65 enforcement actions on cosmetics (lip balm, lipstick, eye products) have established practical compliance thresholds via settlement agreements. EU Cosmetic Regulation 1223/2009 Annex II/III addresses cosmetic-ingredient restrictions but not finished-product action levels. Per CLAUDE.md Part 12, individual brand recall actions are not enumerated here; the recalls are framed as regulatory events that establish the operative compliance landscape.
Sources
Auto-generated from source-page frontmatter. The “Used on this page for” column is populated by the orchestrator’s POPULATE-SOURCE-LEGEND action; pending entries appear as *[awaiting synthesis]*.
| # | Citation | Year | Type | Used on this page for |
|---|---|---|---|---|
| 1 | Almukainzi et al. 2022. Quality and safety investigation of commonly used topical cosmetic preparations, Scientific Reports 12:18299 | 2022 | Peer-reviewed | [awaiting synthesis] |
| 2 | Oranges et al. 2015. Skin Physiology of the Neonate and Infant: Clinical Implications, Advances in Wound Care 4(10): 587-595 | 2015 | Peer-reviewed | [awaiting synthesis] |
Page history
The five most recent substantive edits to this page. The full version history lives in git; when DOI minting comes online (see schema docs), each entry below will also link to a version-pinned DataCite DOI.